5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.61▼ | 4.62▼ | 4.63▼ | 4.64▼ | 5.69▼ |
MA10 | 4.61▼ | 4.59▲ | 4.58▲ | 4.61▲ | 9.91▼ |
MA20 | 4.60▲ | 4.58▲ | 4.56▲ | 6.61▼ | 21.65▼ |
MA50 | 4.56▲ | 4.64▼ | 4.48▲ | 12.60▼ | 16.58▼ |
MA100 | 4.64▼ | 4.55▲ | 5.33▼ | 22.16▼ | 18.63▼ |
MA200 | 4.58▲ | 6.13▼ | 8.03▼ | 17.01▼ | 74.65▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | 0.006▲ | 0.004▲ | 0.290▲ | -2.549▼ |
RSI | 51.202▲ | 50.889▲ | 50.516▲ | 27.115▼ | 31.434▼ |
STOCH | 33.333 | 42.300 | 42.766 | 29.862 | 3.530▼ |
WILL %R | -64.912 | -60.656 | -48.052 | -82.268▼ | -97.190▼ |
CCI | 15.677 | 41.555 | 10.145 | -50.424 | -90.207 |
Thursday, April 17, 2025 07:39 AM
Therefore, it is recommended to visit the company's website for up to date information. Nasdaq Insider Activity page provides trading information of corporate insiders (officers, directors and any ...
|
Sunday, April 06, 2025 03:20 PM
Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today ...
|
Tuesday, April 01, 2025 05:00 PM
Get Aligos Therapeutics alerts: Aligos Therapeutics (NASDAQ:ALGS – Get Free Report) last released its earnings results on Monday, March 10th. The company reported ($13.08) earnings per share for ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
21/04/25 | 4.54 | 4.83 | 4.43 | 4.62 | 111,358 |
17/04/25 | 4.61 | 4.79 | 4.42 | 4.68 | 79,751 |
16/04/25 | 4.63 | 4.97 | 4.33 | 4.57 | 99,057 |
15/04/25 | 4.60 | 5.67 | 4.60 | 4.72 | 267,651 |
14/04/25 | 4.28 | 4.77 | 4.13 | 4.61 | 126,024 |
11/04/25 | 3.98 | 4.35 | 3.76 | 4.08 | 257,744 |
10/04/25 | 4.80 | 4.98 | 3.915 | 3.99 | 309,543 |
09/04/25 | 4.46 | 5.19 | 4.265 | 5.03 | 260,769 |
08/04/25 | 5.57 | 5.79 | 4.51 | 4.71 | 210,943 |
07/04/25 | 5.59 | 5.73 | 4.81 | 5.05 | 428,309 |
|
|
||||
|
|
||||
|
|